DEF 14A
FORM DEF 14A
- Company
- INTEGRATED BIOPHARMA INC
- Filed
- October 28, 2024
- Period of Report
- October 28, 2024
- Accession Number
- 0001437749-24-032295
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →